Linked Life Data

18520164

Source:http://linkedlifedata.com/resource/pubmed/id/18520164

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-6-3
pubmed:abstractText
Fluorescence molecular brain imaging is a new modality allowing the detection of specific contrast agents down to very low concentration ranges (picomolar) in disease models. Here we demonstrate a first noninvasive application of fluorescence imaging in the human brain, where concentrations down to about 100 nM of a nonspecific dye were detected. We argue that due to its high sensitivity, optical molecular imaging of the brain is feasible, which - together with its bedside applicability - makes it a promising technique for use in patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
1660-2862
pubmed:author
pubmed:copyrightInfo
(c) 2008 S. Karger AG, Basel
pubmed:issnType
Electronic
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
296-303
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Towards noninvasive molecular fluorescence imaging of the human brain.
pubmed:affiliation
Clinic of Neurology, Charité - Universitatsmedizin Berlin, Berlin, Germany. jens.steinbrink@charite.de
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't